NCT03714620View on ClinicalTrials.gov

Sub-dissociative Dose Ketamine Dosing Study

PHASE4CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions
Acute Pain
Interventions
DRUG

Ketamine

Ketamine 0.15 mg/kg vs. 0.3 mg/kg IVPB over 15 minutes

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

All Listed Sponsors
lead

Loyola University

OTHER

NCT03714620 - Sub-dissociative Dose Ketamine Dosing Study | Biotech Hunter | Biotech Hunter